Guo M, Sun Y, Wang X, Wang Z, Yuan X, Chen X
Int J Mol Sci. 2024; 25(19).
PMID: 39408814
PMC: 11476373.
DOI: 10.3390/ijms251910486.
Li J, Chen K, Li X, Zhang X, Zhang L, Yang Q
Cell Death Discov. 2023; 9(1):418.
PMID: 37978169
PMC: 10656479.
DOI: 10.1038/s41420-023-01717-2.
Galindo-Vega A, Maldonado-Lagunas V, Mitre-Aguilar I, Melendez-Zajgla J
Cells. 2023; 12(12).
PMID: 37371030
PMC: 10297275.
DOI: 10.3390/cells12121560.
Qi X, Prokhorova A, Mezentsev A, Shen N, Trofimenko A, Filkov G
Int J Mol Sci. 2022; 23(21).
PMID: 36362093
PMC: 9657250.
DOI: 10.3390/ijms232113306.
Tiwari A, Trivedi R, Lin S
J Biomed Sci. 2022; 29(1):83.
PMID: 36253762
PMC: 9575280.
DOI: 10.1186/s12929-022-00866-3.
Novel Drugs with High Efficacy against Tumor Angiogenesis.
Qi S, Deng S, Lian Z, Yu K
Int J Mol Sci. 2022; 23(13).
PMID: 35805939
PMC: 9267017.
DOI: 10.3390/ijms23136934.
Acne Lesion Extraction versus Oral Doxycycline for Moderate Acne Vulgaris: A Randomized Clinical Trial.
Sitohang I, Soebaryo R, Kanoko M
J Clin Aesthet Dermatol. 2021; 14(6):E61-E65.
PMID: 34804358
PMC: 8594536.
In Vivo Assessment of Hypoxia Levels in Pancreatic Tumors Using a Dual-Modality Ultrasound/Photoacoustic Imaging System.
Wang Y, Jhang D, Tsai C, Chiang N, Tsao C, Chuang C
Micromachines (Basel). 2021; 12(6).
PMID: 34200388
PMC: 8229757.
DOI: 10.3390/mi12060668.
Hypoxia and its impact on the tumour microenvironment of gastroesophageal cancers.
King R, Hayes C, Donohoe C, Dunne M, Davern M, Donlon N
World J Gastrointest Oncol. 2021; 13(5):312-331.
PMID: 34040696
PMC: 8131902.
DOI: 10.4251/wjgo.v13.i5.312.
The role of microenvironment in tumor angiogenesis.
Jiang X, Wang J, Deng X, Xiong F, Zhang S, Gong Z
J Exp Clin Cancer Res. 2020; 39(1):204.
PMID: 32993787
PMC: 7526376.
DOI: 10.1186/s13046-020-01709-5.
The Functional Implications of Endothelial Gap Junctions and Cellular Mechanics in Vascular Angiogenesis.
Okamoto T, Usuda H, Tanaka T, Wada K, Shimaoka M
Cancers (Basel). 2019; 11(2).
PMID: 30781714
PMC: 6406946.
DOI: 10.3390/cancers11020237.
Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review.
Yamakawa M, Doh S, Santosa S, Montana M, Qin E, Kong H
Med Res Rev. 2018; 38(6):1769-1798.
PMID: 29528507
PMC: 6135718.
DOI: 10.1002/med.21496.
Gene Expression Profiling of Hepatocellular Carcinoma Derived Cancer Stem Like Cell under Hypoxia.
Choi S, Lee S, Ok M, Kim K, Kim S, Ahn S
Yonsei Med J. 2017; 58(5):925-933.
PMID: 28792135
PMC: 5552646.
DOI: 10.3349/ymj.2017.58.5.925.
Inhibition of HIF-1α Affects Autophagy Mediated Glycosylation in Oral Squamous Cell Carcinoma Cells.
Li Y, Hu J, Wang H
Dis Markers. 2015; 2015:239479.
PMID: 26640316
PMC: 4658405.
DOI: 10.1155/2015/239479.
Expression of nerve growth factor and hypoxia inducible factor-1α and its correlation with angiogenesis in non-small cell lung cancer.
Lu Q, Liu J, Zhu X, Xu W
J Huazhong Univ Sci Technolog Med Sci. 2014; 34(3):359-362.
PMID: 24939299
DOI: 10.1007/s11596-014-1283-3.
Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer.
Reece K, Richardson E, Cook K, Campbell T, Pisle S, Holly A
Mol Cancer. 2014; 13:91.
PMID: 24775564
PMC: 4113146.
DOI: 10.1186/1476-4598-13-91.
Hypoxia inducible factor-1α directly regulates nuclear clusterin transcription by interacting with hypoxia response elements in the clusterin promoter.
Park J, Park S, Shin E, Lee S, Kim Y, Lee D
Mol Cells. 2014; 37(2):178-86.
PMID: 24599003
PMC: 3935631.
DOI: 10.14348/molcells.2014.2349.
A systems biology view of blood vessel growth and remodelling.
Logsdon E, Finley S, Popel A, Mac Gabhann F
J Cell Mol Med. 2013; 18(8):1491-508.
PMID: 24237862
PMC: 4190897.
DOI: 10.1111/jcmm.12164.
Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.
Jacobson O, Chen X
Pharmacol Rev. 2013; 65(4):1214-56.
PMID: 24064460
PMC: 3799232.
DOI: 10.1124/pr.113.007625.
Blockade of VEGFR-1 and VEGFR-2 enhances paclitaxel sensitivity in gastric cancer cells.
Hwang J, Lee J, Park M, Kim D, Bae W, Shim H
Yonsei Med J. 2013; 54(2):374-80.
PMID: 23364970
PMC: 3575962.
DOI: 10.3349/ymj.2013.54.2.374.